Hemophilia Gene Therapy Market - Size, Growth Dynamics & Forecast (2024-2032)
The treatment for Hemophilia, a challenging inherited bleeding disorder, has historically involved frequent, costly intravenous injections of clotting factors. However, we are entering a new era of medicine where a one-time treatment may offer a near-cure. Gene therapy—the process of introducing a functional copy of the deficient clotting factor gene directly into a patient’s...
0 Comentários 0 Compartilhamentos 9 Visualizações 0 Anterior